globe usa magnifying-glass checkbox g-plus rss youtube fb-round connect-with-us-in connect-with-us-twitter youtube2 facebook linkedin twitter
The website you have requested may contain information on products or uses of such products that are not approved in your country. For specific product and country information please contact Medinol

The Belgian Registry

  • A non-randomized single arm registry, evaluating the safety of NIRxcell Stent
  • 101 patients enrolled in Belgium and Luxembourg
  • De novo stenotic lesions in native coronary arteries
  • Primary endpoint: composite of MACE (cardiac death, MI and clinically-driven TLR) at 30 days and 6 months
  • Result: MACE at 30 days was 0 and at the 6-12 months period it was 7.9%